Fujian Wanchen Biotechnology Co. Ltd Total Liabilities

Latest as of March 2026: CN¥7.34 Billion CNY ≈ $1.07 Billion USD

Fujian Wanchen Biotechnology Co. Ltd total liabilities. Based on the latest financial reports, Fujian Wanchen Biotechnology Co. Ltd (300972) has total liabilities worth CN¥7.34 Billion CNY (≈ $1.07 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Fujian Wanchen Biotechnology Co. Ltd's assets to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Fujian Wanchen Biotechnology Co. Ltd (2019–2025)

Total liabilities of Fujian Wanchen Biotechnology Co. Ltd from 2019 to 2025. This chart illustrates how Fujian Wanchen Biotechnology Co. Ltd's total liabilities have evolved over time, based on quarterly financial data.

Fujian Wanchen Biotechnology Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Fujian Wanchen Biotechnology Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
HOSHIZAKIL UNSP.ADR/025 F:HS00	Germany	€161.73 Billion
CCC Intelligent Solutions Holdings Inc. NASDAQ:CCC	USA	$1.76 Billion
Springer Nature AG & Co KGaA F:SPG	Germany	€3.26 Billion
Millrose Properties, Inc. NYSE:MRP	USA	$3.86 Billion
Ecovacs Robotics Co Ltd SHG:603486	China	CN¥8.65 Billion
Liaoning Port Co Ltd SHG:601880	China	CN¥13.29 Billion
Nanjing Iron & Steel Co Ltd SHG:600282	China	CN¥40.74 Billion
Legend Biotech Corp NASDAQ:LEGN	USA	$521.32 Million

Liability Composition Analysis (2019–2025)

This chart breaks down Fujian Wanchen Biotechnology Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Fujian Wanchen Biotechnology Co. Ltd asset portfolio.

Liquidity & Leverage Metrics

Fujian Wanchen Biotechnology Co. Ltd Total Liabilities Ratios Explained

Fujian Wanchen Biotechnology Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.55	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.64	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.68	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Fujian Wanchen Biotechnology Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)

The table below shows the annual total liabilities of Fujian Wanchen Biotechnology Co. Ltd from 2019 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥7.50 Billion ≈ $1.10 Billion	+29.43%
2024-12-31	CN¥5.79 Billion ≈ $847.56 Million	+79.35%
2023-12-31	CN¥3.23 Billion ≈ $472.58 Million	+510.75%
2022-12-31	CN¥528.79 Million ≈ $77.38 Million	+151.24%
2021-12-31	CN¥210.47 Million ≈ $30.80 Million	-18.40%
2020-12-31	CN¥257.94 Million ≈ $37.74 Million	-17.01%
2019-12-31	CN¥310.81 Million ≈ $45.48 Million	--

About Fujian Wanchen Biotechnology Co. Ltd

SHE:300972 China Farm Products

Market Cap

$3.99 Billion

CN¥27.26 Billion CNY

Market Cap Rank

#3997 Global

#533 in China

Share Price

CN¥140.37

Change (1 day)

-6.09%

52-Week Range

CN¥133.88 - CN¥232.89

All Time High

CN¥232.89